An interferon gamma-gp120 fusion delivered as a DNA vaccine induces enhanced priming

Vaccine

Volumn 23, Issue 30, 2005, Pages 3984-3990

  Nimal, Sonali ^a   McCormick, Adele L ^a,b   Thomas, Mark S ^a   Heath, Andrew W ^a  

^a UNIVERSITY OF SHEFFIELD   (United Kingdom)

^b UNIVERSITY COLLEGE LONDON   (United Kingdom)

Author keywords

Adjuvant; gp120; Interferon gamma

Indexed keywords

ADJUPHOS; ADJUVANT; ALUMINUM POTASSIUM SULFATE; DNA VACCINE; HYBRID PROTEIN; IMMUNOGLOBULIN G2A; INTERFERON GAMMA GLYCOPROTEIN GP120; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DRUG DELIVERY SYSTEM; DRUG FORMULATION; FEMALE; IMMUNE RESPONSE; IMMUNOGENICITY; MOUSE; NONHUMAN; PLASMID; PRIORITY JOURNAL; TH1 CELL; VACCINATION;

ADJUVANTS, IMMUNOLOGIC; AIDS VACCINES; ALUM COMPOUNDS; ANIMALS; ANTIBODIES, VIRAL; CELL PROLIFERATION; CYTOKINES; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HIV ENVELOPE PROTEIN GP120; INTERFERON-GAMMA, RECOMBINANT; MICE; MICE, INBRED BALB C; T-LYMPHOCYTES; VACCINES, DNA;

EID: 19444368802     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.vaccine.2005.01.160     Document Type: Article

References (34)

1. S. Gurunathan, D.M. Klinman, and R.A. Seder DNA vaccines: immunology, application, and optimization Annu Rev Immunol 18 2000 927 974
2. M.A. Liu DNA vaccines: a review J Int Med 253 2003 402 410
3. M. Yokoyama, J. Zhang, and J.L. Whitton DNA immunization: effects of vehicle and route of administration on the induction of protective antiviral immunity FEMS Immunol Med Microbiol 14 1996 221 230
4. N. Ishii, J. Fukushima, T. Kaneko, E. Okada, K. Tani, and S.I. Tanaka Cationic liposomes are a strong adjuvant for a DNA vaccine of human immunodeficiency virus type 1 AIDS Res Hum Retroviruses 13 1997 1421 1428
5. S. Sasaki, T. Tsuji, K. Hamajima, J. Fukushima, N. Ishii, and T. Kaneko Monophosphoryl lipid A enhances both humoral and cell-mediated immune responses to DNA vaccination against human immunodeficiency virus type 1 Infect Immun 65 1997 3520 3528
6. J.B. Ulmer, C.M. DeWitt, M. Chastain, A. Friedman, J.J. Donelly, and W.L. McClements Enhancement of DNA vaccine potency using conventional aluminium adjuvants Vaccine 18 1999 18 28
7. S. Wang, X. Liu, K. Fisher, J.G. Smith, F. Chen, and T.W. Tobery Enhanced type I immune response to a hepatitis B DNA vaccine by formulation with calcium- or aluminum phosphate Vaccine 18 2000 1227 1235
8. M. Kwissa, E.B. Lindblad, R. Schirmbeck, and J. Reimann Codelivery of a DNA vaccine and a protein vaccine with aluminium phosphate stimulates a potent and multivalent immune response J Mol Med 81 2003 502 510
9. Y.H. Chow, W.L. Huang, W.K. Chi, and Y.D. Chu Improvement of hepatitis B virus DNA vaccines by plasmids co-expressing hepatitis B surface antigen and Interleukin-2 J Virol 71 1997 169 178
10. E. Okada, S. Sasaki, N. Ishii, I. Aoki, T. Yasuda, and K. Nishioka Intranasal immunization of a DNA vaccine with IL-12 and granulocyte-macrophage colony-stimulating factor (GM-CSF) expressing plasmids in liposomes induces strong mucosal and cell-mediated immune responses against HIV-1 antigens J Immunol 159 1997 3638 3647
11. J.J. Kim, V. Ayyavoo, M.L. Bagarazzi, M. Chatergoon, J.D. Boyer, and B. Wang Development of a multicomponent candidate vaccine for HIV-1 Vaccine 15 1997 879 883
12. Y. Chow, B. Chiang, Y. Lee, and W. Chi Development of TH1 and TH2 populations and the nature of immune responses to hepatitis B virus DNA vaccines can be modulated by co-delivery of various cytokine genes J Immunol 160 1998 1320 1329
13. J.J. Kim, N.N. Triwedi, L.K. Nottingham, and L. Morrison Modulation of amplitude and direction of in vivo immune responses by co-administration of cytokine gene expression cassettes with DNA immunogens Eur J Immunol 28 1998 1089 1103
14. J.I. Sin, J.J. Kim, K.E. Ugen, R.B. Ciccarelli, T.J. Higgins, and D.B. Weiner Enhancement of protective humoral (Th2) and cell-mediated (Th1) immune responses against herpes simplex virus-2 through co-delivery of granulocyte-macrophage colony-stimulating factor expression cassettes Eur J Immunol 28 1998 3530 3540
15. J.J. Kim, J.S. Yang, T.C. Vancott, D.J. Lee, K.H. Manson, and M.S. Wyand Modulation of antigen-specific humoral responses in rhesus macaques by using cytokine cDNA as DNA vaccine adjuvants J Virol 74 2000 3427 3429
16. M. Eblerl, E. Beck, P.S. Coulson, H. Okamura, A.R. Wilson, and A.P. Mountford IL-18 potentiates the adjuvant properties of IL-12 in the induction of a strong Th1 type immune response against a recombinant antigen Vaccine 18 2000 2002 2008
17. D.H. Barouch, S. Santra, J.E. Schmitz, M.J. Kuroda, T.N. Fu, and W. Wagner Control or viremia and prevention of clinical AIDS in rhesus monkeys by cytokine-augmented DNA vaccination Science 290 2000 486 492
18. J. Flo, S. Tisminetzky, and F. Baralle Modulation of the immune response to DNA vaccine by co-delivery of co-stimulatory molecules Immunology 100 2000 259 267
19. L.J. Liu, S. Watabe, J. Yang, K. Hamajima, N. Ishii, and E. Hagiwara Topical application of HIV DNA vaccine with cytokine-expression plasmids induces strong antigen-specific immune responses Vaccine 20 2002 42 48
20. S. Lee, M. Gierynska, S.K. Eo, N. Kuklin, and B.T. Rouse Influence of DNA encoding cytokines on systemic and mucosal immunity following genetic vaccination against herpes simplex virus Microbes Infect 5 2003 571 578
21. T.R. Jones, R.A. Gramzinski, J.C. Aguiar, B.K. Simm, D.L. Narum, and S.R. Fuhrmann Protection of Aotus monkeys by Plasmodium falciparum EBA-175 region II DNA prime-protein boost immunization regime J Infect Dis 183 2001 303 312
22. J. Schneider, S.C. Gilbert, T.J. Blanchard, T. Hanke, K.J. Robson, and C.M. Hannan Enhanced immunogenicity for CD8+Tcell induction and complete protective efficacy of malaria DNA vaccination by boosting with modified vaccinia virus Ankara Nat Med 4 1998 397 402
23. S.J. Kent, A. Zhao, S.J. Best, J.D. Chandler, D.B. Boyle, and I.A. Ramshaw Enhanced T-cell immunogenicity and protective efficacy of a human immunodeficiency virus type 1 vaccine regimen consisting of consecutive priming with DNA and boosting with recombinant fowlpox virus J Virol 72 1998 180 188
24. H.L. Robinson, D.C. Montefiori, R.P. Johnson, K.H. Manson, M.L. Kalish, and J.D. Lifson Neutralising antibody-independent containment of immunodeficiency virus challenges by DNA priming and recombinant pox virus booster immunizations Nat Med 5 1999 526 534
25. R.R. Amara, F. Villinger, J.D. Altman, S.L. Lydy, S.P. O'Neil, and S.I. Staprans Control of a mucosal challenge and prevention of AIDS by multiprotein DNA/MVA vaccine Science 292 2001 69 74
26. M.H. Tao, and R. Levy Idiotype/granulocyte-macrophage colony-stimulating factor fusion protein as a vaccine for B-cell lymphoma Nature 362 1993 755 758
27. T.T. Chen, M.H. Tao, and R. Levy Idiotype-cytokine fusion proteins as cancer vaccine. Relative efficacy of IL-2, IL-4, and granulocyte-macrophage colony-stimulating factor J Immunol 153 1994 4775 4787
28. L. Faulker, G. Buchan, E. Lockhart, L. Slobbe, M. Wilson, and M. Baird IL-2 linked to a peptide from influenza hemagglutinin enhances T cell activation by affecting the antigen-presentation function of bone marrow-derived dendritic cells Int Immunol 13 2001 713 721
29. J.H.L. Playfair, and J.B. De Souza Recombinant gamma-interferon is a potent adjuvant for a malaria vaccine in mice Clin Exp Immunol 67 1987 5 10
30. A.W. Heath, M. Devey, I. Brown, C.E. Richards, and J.H.L. Playfair Interferon gamma as an adjuvant in immuno-compromised mice Immunology 67 1989 520 524
31. A.W. Heath, and J.H.L. Playfair Cytokines as immunological adjuvants Vaccine 10 1992 427 443
32. A.W. Heath, and J.H.L. Playfair Conjugation of interferon gamma to antigen enhances its adjuvanticity Immunology 71 1990 454 456
33. A.L. McCormick, M.S. Thomas, and A.W. Heath Immunization with interferon gamma-gp120 fusion protein induces enhanced immune responses to human immunodeficiency virus gp120 J Infect Dis 184 2001 1423 1430
34. C. Vella, M.H. Smith, G.H. Farrar, D.H. Jones, and R.S. Daniels A molecular and serologic study of the envelope gene of the British isolate HIV-1 GB8 Vaccine 13 1995 735 741